Literature DB >> 18313040

Neuroendocrine hormones such as growth hormone and prolactin are integral members of the immunological cytokine network.

Doug Redelman1, Lisbeth A Welniak, Dennis Taub, William J Murphy.   

Abstract

Neuroendocrine hormones such as growth hormone (GH) and prolactin (PRL) have been demonstrated to accelerate the recovery of the immune response after chemotherapy and bone marrow transplantation and to enhance the restoration of immunity in individuals infected with HIV and in normal individuals with compromised immune systems associated with aging. As the mechanism of action of these hormones has been elucidated, it has become clear that they are integral members of the immunological cytokine/chemokine network and share regulatory mechanisms with a wide variety of cytokines and chemokines. The members of this cytokine network induce and can be regulated by members of the suppressor of cytokine signaling (SOCS) family of intracellular proteins. In order to take advantage of the potential beneficial effects of hormones such as GH or PRL, it is essential to take into consideration the overall cytokine network and the regulatory effects of SOCS proteins.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18313040      PMCID: PMC4777337          DOI: 10.1016/j.cellimm.2007.12.003

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  99 in total

1.  Characterization of the human growth hormone receptor gene and demonstration of a partial gene deletion in two patients with Laron-type dwarfism.

Authors:  P J Godowski; D W Leung; L R Meacham; J P Galgani; R Hellmiss; R Keret; P S Rotwein; J S Parks; Z Laron; W I Wood
Journal:  Proc Natl Acad Sci U S A       Date:  1989-10       Impact factor: 11.205

2.  SOCS up-regulation mobilizes autologous stem cells through CXCR4 blockade.

Authors:  Oscar M Pello; María del Carmen Moreno-Ortiz; José Miguel Rodríguez-Frade; Laura Martínez-Muñoz; Daniel Lucas; Lucio Gómez; Pilar Lucas; Enrique Samper; Miguel Aracil; Carlos Martínez; Antonio Bernad; Mario Mellado
Journal:  Blood       Date:  2006-08-15       Impact factor: 22.113

3.  Intracellular protein therapy with SOCS3 inhibits inflammation and apoptosis.

Authors:  Daewoong Jo; Danya Liu; Shan Yao; Robert D Collins; Jacek Hawiger
Journal:  Nat Med       Date:  2005-07-10       Impact factor: 53.440

4.  Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone.

Authors:  Laura A Napolitano; Joan C Lo; Michael B Gotway; Kathleen Mulligan; Jason D Barbour; Diane Schmidt; Robert M Grant; Robert A Halvorsen; Morris Schambelan; Joseph M McCune
Journal:  AIDS       Date:  2002-05-24       Impact factor: 4.177

5.  Immune function in transgenic mice overexpressing growth hormone (GH) releasing hormone, GH or GH antagonist.

Authors:  E Dialynas; H Brown-Borg; A Bartke
Journal:  Proc Soc Exp Biol Med       Date:  1999-07

6.  Growth hormone synthesized and secreted by human thymocytes acts via insulin-like growth factor I as an autocrine and paracrine growth factor.

Authors:  P Sabharwal; S Varma
Journal:  J Clin Endocrinol Metab       Date:  1996-07       Impact factor: 5.958

7.  Ghrelin is a growth-hormone-releasing acylated peptide from stomach.

Authors:  M Kojima; H Hosoda; Y Date; M Nakazato; H Matsuo; K Kangawa
Journal:  Nature       Date:  1999-12-09       Impact factor: 49.962

8.  Differential expression of surface membrane growth hormone receptor on human peripheral blood lymphocytes detected by dual fluorochrome flow cytometry.

Authors:  R Badolato; H M Bond; G Valerio; A Petrella; G Morrone; M J Waters; S Venuta; A Tenore
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

Review 9.  Growth hormone and a partial mediator of its biological action, insulin-like growth factor I.

Authors:  Y A Pankov
Journal:  Biochemistry (Mosc)       Date:  1999-01       Impact factor: 2.487

10.  Loss of the CD56hiCD16- NK cell subset and NK cell interferon-gamma production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone.

Authors:  M R Goodier; N Imami; G Moyle; B Gazzard; F Gotch
Journal:  Clin Exp Immunol       Date:  2003-12       Impact factor: 4.330

View more
  19 in total

Review 1.  Rejuvenation of the aging thymus: growth hormone-mediated and ghrelin-mediated signaling pathways.

Authors:  Dennis D Taub; William J Murphy; Dan L Longo
Journal:  Curr Opin Pharmacol       Date:  2010-06-04       Impact factor: 5.547

Review 2.  Thymus: the next (re)generation.

Authors:  Mohammed S Chaudhry; Enrico Velardi; Jarrod A Dudakov; Marcel R M van den Brink
Journal:  Immunol Rev       Date:  2016-05       Impact factor: 12.988

3.  Preliminary Evidence of Increased Pain and Elevated Cytokines in Fibromyalgia Patients with Defective Growth Hormone Response to Exercise.

Authors:  Rebecca L Ross; Kim D Jones; Robert M Bennett; Rachel L Ward; Brian J Druker; Lisa J Wood
Journal:  Open Immunol J       Date:  2010

4.  Increased circulating IL-8 is associated with reduced IGF-1 and related to poor metabolic control in adolescents with type 1 diabetes mellitus.

Authors:  Bradley J Van Sickle; Jill Simmons; Randon Hall; Miranda Raines; Kate Ness; Anna Spagnoli
Journal:  Cytokine       Date:  2009-09-20       Impact factor: 3.861

Review 5.  Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines.

Authors:  Chandrani Sarkar; Debanjan Chakroborty; Sujit Basu
Journal:  J Neuroimmune Pharmacol       Date:  2012-08-11       Impact factor: 4.147

Review 6.  The immune system and developmental programming of brain and behavior.

Authors:  Staci D Bilbo; Jaclyn M Schwarz
Journal:  Front Neuroendocrinol       Date:  2012-09-09       Impact factor: 8.606

7.  Neuroendocrine interactions in the immune system.

Authors:  Dennis D Taub
Journal:  Cell Immunol       Date:  2008-07-10       Impact factor: 4.868

Review 8.  Prolactin and autoimmunity.

Authors:  Luis J Jara; Gabriela Medina; Miguel A Saavedra; Olga Vera-Lastra; Carmen Navarro
Journal:  Clin Rev Allergy Immunol       Date:  2011-02       Impact factor: 8.667

9.  Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients.

Authors:  Gabriel Morrhaye; Hamid Kermani; Jean-Jacques Legros; Frederic Baron; Yves Beguin; Michel Moutschen; Remi Cheynier; Henri J Martens; Vincent Geenen
Journal:  PLoS One       Date:  2009-05-22       Impact factor: 3.240

Review 10.  Dual Characters of GH-IGF1 Signaling Pathways in Radiotherapy and Post-radiotherapy Repair of Cancers.

Authors:  Yunyun Cheng; Wanqiao Li; Ruirui Gui; Chunli Wang; Jie Song; Zhaoguo Wang; Xue Wang; Yannan Shen; Zhicheng Wang; Linlin Hao
Journal:  Front Cell Dev Biol       Date:  2021-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.